Daiichi Life Group (DLICY) Fair Value & Analysis
Financial Services · US · Market cap $39.8B
Daiichi Life Group
DLICY · US
Fair value as of: Jul 26, 2026
From 24 valuation models · updated 12 days ago
Fair value updated Jul 26, 2026, revised from $20.67 to $20.41 (−1.3%) since Jun 26, 2026. Share price +6.0% over the past month.
A solid business, but screening 16% overvalued on our models.
What matters now
- Solid but not exceptional quality (66/100) and above fair value, neither a clear bargain nor a standout compounder.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 26, 2026.
How to read this chart
60‑month range $3.96 – $24.21 · fair‑value band $15.31 – $25.51 · the $24.21 price screens above the $20.41 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 26, 2026.
Analysis
Daiichi Life Group (DLICY) currently trades at $24.21, while our model-based Fair Value estimate is $20.41, implying the stock looks roughly 15.7% overvalued today. We read business quality at 66/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Daiichi Life Group generated revenue of $10.2T at a net margin of 4.3%. Revenue grew 26.3% year over year. It earns a return on equity of 11.1%. The balance sheet holds a net cash position of $2.6T. Fundamentals as of Jul 26, 2026
Our scenario range runs from $15.31 (bear case) to $25.51 (bull case); at $24.21, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 80% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 1% fair-value upside, at -16%, DLICY screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models ($29.41) versus Earnings-Based ($5.67). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 26, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 48 · Market factors (momentum, volatility) 90
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Daiichi Life Group, Inc., through its subsidiaries, provides insurance products in Japan, the United States, and internationally. The company operates through three segments: Domestic Insurance Business, Overseas Insurance Business, and Other Business.
Full company description
Daiichi Life Group, Inc., through its subsidiaries, provides insurance products in Japan, the United States, and internationally. The company operates through three segments: Domestic Insurance Business, Overseas Insurance Business, and Other Business. It offers educational endowment insurance, individual annuity, variable product, investment trust, lump-sum payment products, group annuity plans, succession products, medical and cancer protection, saving-type disease protection, health promotion, health protection (palliative care), group insurance, death protection, nursing care and dementia protection, and income and disease protection. The company was formerly known as Dai-ichi Life Holdings, Inc. and changed its name to Daiichi Life Group, Inc. in April 2026. The company was incorporated in 1902 and is headquartered in Tokyo, Japan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Daiichi Life Group reported revenue of $10.3T in FY2026 versus $7.9T in FY2022, a compound +7.0%/yr. Reported net income was $463B in FY2026, compounding +3.1%/yr from FY2022.
DLICY screens 16% overvalued. Compare with China Life Insurance Company →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Is It Too Late To Consider Daiichi Life Group (TSE:8750) After A 1-Year 50% Rally?
- Daiichi Life FY26 Earnings Slip Despite Higher Revenue; Guides FY27
Peer Group
Insurance - Life · 96 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Insurance - Life median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Insurance - Life stocks, each showing price versus our Fair Value estimate (as of Jul 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| China Life Insurance Company 601628 | ¥38.72 | ¥70.87 | +83% |
| Ping An Insurance (Group) Company 601318 | ¥49.60 | ¥96.76 | +95% |
| AIA Group 1299 | HK$75.55 | HK$7.88 | -90% |
| Manulife Financial Corporation MFC | C$58.52 | C$45.13 | -23% |
| Great-West Lifeco Inc GWO | C$92.34 | C$59.64 | -35% |
| Life Insurance Corporation LICI | ₹438.30 | ₹590.43 | +35% |
| Fubon Financial Holding 2881 | 124.50 TWD | 115.05 TWD | -8% |
| Cathay Financial Holding 2882 | 94.00 TWD | 94.95 TWD | +1% |
| Samsung Life Insurance Co 032830 | 337,500 KRW | 166,710 KRW | -51% |
| China Pacific Insurance (Group) Co 601601 | ¥29.75 | ¥59.50 | +100% |
Compare Daiichi Life Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Daiichi Life Group (DLICY) overvalued or undervalued?
What is the fair value of DLICY?
What is the quality score of DLICY?
What is the revenue of Daiichi Life Group (DLICY)?
What is the net profit margin of DLICY?
Does Daiichi Life Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Daiichi Life Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.